Chapter One — 1.1 Background to the Study

In recent years, Immunization Coverage has emerged as a critical factor shaping disease prevalence across organizations operating in and around Selected Federal Government Parastatals in Nigeria. As institutions grapple with the pressures of globalization, regulatory reform, and shifting stakeholder expectations, understanding how immunization coverage relates to disease prevalence has become an important area of both scholarly and practical concern.

Within the context of Selected Federal Government Parastatals in Nigeria, this relationship carries particular significance. Organizations in this setting operate under a distinct combination of economic, regulatory, and market conditions that may amplify or dampen the effect of immunization coverage on disease prevalence, making a context-specific inquiry both timely and necessary.

1.2 Statement of the Problem

While immunization coverage is widely discussed in policy and industry circles, empirical evidence on its actual effect on disease prevalence within Selected Federal Government Parastatals in Nigeria remains sparse and, in places, contradictory. This lack of localized, rigorous evidence makes it difficult for decision-makers to know with confidence whether current approaches to immunization coverage are helping or hindering disease prevalence — a gap this study sets out to close.

1.3 Objectives of the Study

1. To examine the effect of Immunization Coverage on disease prevalence in Selected Federal Government Parastatals in Nigeria.
2. To assess the extent to which immunization coverage influences disease prevalence within the study area.
3. To identify the challenges associated with immunization coverage in relation to disease prevalence.
4. To recommend strategies for optimizing immunization coverage in order to improve disease prevalence.

1.4 Research Questions

1. What is the effect of immunization coverage on disease prevalence in Selected Federal Government Parastatals in Nigeria?
2. To what extent does immunization coverage influence disease prevalence within the study area?
3. What challenges are associated with immunization coverage in relation to disease prevalence?
4. What strategies can be adopted to optimize immunization coverage in order to improve disease prevalence?

1.5 Significance of the Study

This study is significant to a range of stakeholders. For policymakers and regulators, the findings offer evidence to guide the design of frameworks that support healthier outcomes around disease prevalence. For managers and practitioners within Selected Federal Government Parastatals in Nigeria, the study provides practical insight into how immunization coverage can be better managed. Finally, it contributes to the academic literature on public health by extending existing knowledge into a specific empirical context, and offers a reference point for future researchers.

1.6 Scope of the Study

The study is limited to an examination of Immunization Coverage and its relationship with disease prevalence within the context of Selected Federal Government Parastatals in Nigeria. It reflects a BSc-level scope of analysis and relies on data and perspectives available within that scope; generalizing the findings beyond this specific context should therefore be done with appropriate caution.